Blood test may cut hospital stays for preeclampsia

NCT ID NCT03289611

Completed Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a blood test measuring the sFlt-1/PlGF ratio can help doctors decide the best care for pregnant people with suspected preeclampsia before 35 weeks. 84 participants were randomly assigned to have their care guided by the test or usual care. The goal was to see if the test could reduce hospital stays and costs while keeping mothers and babies safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sFlt-1/PlGF ratio blood test
What this could lead to: If successful, this test could help doctors decide who needs hospital care for preeclampsia, reducing unnecessary stays and costs.
What could go wrong: This is a small, completed study with 84 participants. The test may not be accurate enough for all patients, and results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREECLAMPSIA

Contacts and locations

Locations

CHU Cochin, Maternité Port Royal

Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.